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Special issue: Animal models of diseaseAnimal models are a vital resource for modern biomedical re-
search. The variety and complexity of animal models available to re-
searchers have increased remarkably over the past several decades,
and now encompass a wide range of species, both vertebrate and
invertebrate. Although there have been some modest advances in
non-animal alternatives in recent years, we still rely on animalmodels
as a means to obtain answers to difﬁcult biological questions that can-
not (as yet) be found in otherways. Given our incomplete understand-
ing of whole organism physiology, it is likely that this situation will
continue for the foreseeable future.
When we think of animal models of human disease, we often
think of genetically modiﬁed mice. Introducing a genetic change into
a mouse line, either by generating a transgenic mouse or through
gene targeted knock-in or knock-out, has become a standard method
of studying the mechanisms that underlie many human diseases. Fur-
ther, many human diseases have no ready animal counterpart, and
introducing a genetic modiﬁcation into a suitable organism can often
at least partially mimic the disease. This has the added advantage of
creating a system that might theoretically be used to develop and
test potential therapeutics. Although mice are the most widely used
mammalian models, this technology is now more common in rats,
and in some larger animal species as well. Zebraﬁsh are only recently
being tapped as important vertebrate models, and their true potential
will likely be realized in the very near future.
There is no denying that we can do a better job of reﬁning our
model systems. This can be thought of not only as ameans of obtaining
a better understanding of disease, but also from the perspective of
improving animal welfare. Understanding diet and metabolism, and
the role of modiﬁer genes, will be an important part of this process.
As our models grow in both ambition and complexity, this area repre-
sents the greatest potential for innovation and growth. This special
issue only scratches the surface of where we can go in the future.0925-4439/$ – see front matter © 2013 Published by Elsevier B.V.
http://dx.doi.org/10.1016/j.bbadis.2013.05.024Dr. Murphy has worked as a researcher in the areas of
aging and neurodegenerative disease for more than
20 years (starting with his M.A. degree, in psychology,
at the University of Toronto, followed by a Ph.D. in neu-
roscience). He began to focus on Alzheimer's disease
(AD) while a post-doctoral fellow at the Mayo Clinic in
Jacksonville, FL, in the lab of Todd Golde. He moved to
the University of Kentucky in 2005. His lab studies the
production of the amyloid-β peptide (Aβ), the regulation
of these processes, and how the peptide ultimately causes
AD pathology in the brain. His lab has a strong focus on
models of disease, mainly genetically modiﬁed mice, but
also in higher mammals and in cultured cells. Dr. Murphy
has been engaged throughout his career in basic research,
preclinical translational research, and in the early stages of human clinical trials.
Dr. Murphy has authored or co-authored almost 90 journal articles, including inﬂuen-
tial articles in Science, Nature, Nature Medicine, and recently (this past year) in the
Annals of Neurology and the American Journal of Pathology. In 2010, Dr. Murphy
was honored by the receipt of the Thomas Maciag Award from NIH for exemplifying
research excellence and innovation, and for the mentorship of new scientists.
Dr. Murphy is probably best known for the study and development of different
models of AD and related pathology. Several of the mouse models that he was in-
volved with from the development stage onwards are well known and widely used
in the AD ﬁeld, and he has several notable papers exploring AD pathology in elderly
cats, dogs, and people. Dr. Murphy's recent research, includes understanding how life
style choices, particularly those that lead to obesity and type 2 diabetes, can eventu-
ally lead to neurologic disease.M. Paul Murphy
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